Alexion Pharmaceuticals Inc ALXN:NASDAQ

Last Price$115.33NASDAQ Previous Close - Last Trade as of 4:00PM ET 8/23/19
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$115.50 (1)
Ask (Size)$118.50 (21)
Day Low / HighN/A - N/A
Volume5.2 M
  • Latest Stories
  • Commentary and Analysis
Sector Update: Top Health Care Stocks Flat to Lower Pre-Market Friday
9:24AM ET 8/23/2019 MT Newswires

Top Health Care Stocks: JNJ: -0.17% PFE: Flat ABT: -0.90% MRK: -0.59% AMGN: -1.2% Top health care stocks were flat to lower in pre-market trading Friday. ...

Sector Update: Health Care
8:54AM ET 8/23/2019 MT Newswires

Top health care stocks were flat to lower pre-market Friday. In other sector news, Alexion Pharmaceuticals (ALXN) was marginally higher after saying the...

--Analyst Actions: JPMorgan Starts Alexion Pharmaceuticals at Overweight, Lowers PT to $172 From $179
10:59AM ET 7/31/2019 MT Newswires

Price: 115.11, Change: +0.66, Percent Change: +0.58 ...

Q3, 2019, and 2020 Earnings Estimates for Alexion Pharmaceuticals Increased
11:36PM ET 7/29/2019 MT Newswires

Q3, 2019, and 2020`s earnings projections for Alexion Pharmaceuticals Inc (NASDAQ:ALXN, Recent Price: 112.36) have been scaled up. The Q3 earnings estimate...

Alexion Pharmaceuticals Gets Positive Opinion from European Agency for Treatment of Neuro Disorder
3:24PM ET 7/26/2019 MT Newswires

Alexion Pharmaceuticals (ALXN) said Friday that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a...

Alexion Pharmaceuticals' Q3, 2019 and 2020 Earnings Estimates Raised
11:26PM ET 7/25/2019 MT Newswires

Q3, 2019, and 2020`s forecasted earnings estimates for Alexion Pharmaceuticals Inc (NASDAQ:ALXN, Recent Price: 118.03) have been revised upward. The Q3...

Alexion Pharmaceuticals Q2 Results Exceed Estimates on Earnings, Revenue; Raises 2019 Outlook
7:26AM ET 7/24/2019 MT Newswires

Alexion Pharmaceuticals (ALXN) reported pre-market Wednesday Q2 adjusted EPS of $2.64, a 28% increase from last year and ahead of consensus compiled by...

--GUIDANCE: (ALXN) ALEXION PHARMA Fiscal Year Revenue Range $4.75B - $4.8B
6:32AM ET 7/24/2019 MT Newswires

...

--(ALXN) ALEXION PHARMA Q2 Revenue $1.203B, 2.5% Surprise
6:32AM ET 7/24/2019 MT Newswires

...

--GUIDANCE: (ALXN) ALEXION PHARMA Fiscal Year EPS Range $9.65 - $9.85
6:32AM ET 7/24/2019 MT Newswires

...